# High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis

> **NCT06897384** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 388 (estimated)

## Conditions studied

- Severe Acute Pancreatitis

## Interventions

- **DRUG:** Saline (NaCl 0,9 %)
- **DRUG:** Vitamin C (Ascorbic Acid)

## Key facts

- **NCT ID:** NCT06897384
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 388 (ESTIMATED)
- **Last updated:** 2025-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06897384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06897384, "High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06897384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*